ARGENX SE

ARGX · XNAS

CIK 1697862fmd_15S216ZZ7GMX0CBJDGH2BPSANDManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2015 to Dec 31, 2025, 20 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.